PT Ekadharma International Tbk (EKAD.JK)
Tangerang, ID
PT Ekadharma International Tbk, alongside its affiliated companies, operates as a leading producer and vendor of self-adhesive tapes throughout Indonesia and Malaysia. Its comprehensive range of adhesive products includes aluminum foil, anti-slip, cling wrap, double foam, cloth, double-sided, epoxy glue, kraft, masking, metalizing, OPP, OPP printing, PVC electrical insulation, and stationary tapes. Beyond its core tape offerings, the company also supplies stretch film, as well as various glues such as water, white, super glue, and glue sticks, all marketed under the DAIMARU, SUPERFIX, and EKATAPE brands. Furthermore, PT Ekadharma International provides packaging machinery, featuring adjustable carton sealers with fold flap closers, several models of semi-automatic carton sealers (top drive, side drive, and random), and semi-automatic stretch wrappers, all bearing the BESTPACK brand. Established in 1981, the firm, which was previously known as PT Ekadharma Widya Grafika before its name change in 2006, maintains its corporate headquarters in Tangerang, Indonesia, and operates as a subsidiary of PT Ekadharma Inti Perkasa.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.58% | -0.58% | -3.91% | -9.47% | -9.47% | -6.52% | -11.79% | -35.82% | -33.85% | +70.30% | +561.54% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-0.2% Q1'26: +10.7% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-17.7% Q1'26: -42.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+8.5% Q1'26: +7.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+9.9% ★ Q1'26: +8.5% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+5.9% ★ Q1'26: +4.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.31× ★ Q1'26: 0.30× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-26 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-25 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-22 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-21 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-20 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-19 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-18 | A | 4/5 | 5/5 | 3/5 | 4/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-08 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-07 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-06 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-05 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-05-04 | A+ | 4/5 | 5/5 | 3/5 | 5/5 | 3/5 | 3/5 | 5/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-04-29 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 3/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ade Fitriani Herawati | Accounting Manager | — | — |
| Denny Purnama Adi Chandra | Credit & Collection Manager | — | — |
| Dominicus Da Silva | HRD Manager | — | — |
| Judi Widjaja Leonardi | President Director | — | female |
| Lie Phing | Finance & Admin Director, Corporate Secretary and Director | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EKAD.JK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
